Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07730567
PHASE1
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
To evaluate the pharmacokinetic interaction and the safety of AD-236A and AD-236B in healthy adult volunteers
Official title: A Two-arm, Open-label, Single-sequence, Multiple-dose Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2026-07-29
Completion Date
2026-09-26
Last Updated
2026-07-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Treatment A(AD-236A)
AD-236A Oral Tablet
DRUG
Treatment B(AD-236B)
AD-236B Oral Tablet
DRUG
Treatment C(AD-236A+AD-236B)
AD-236A+AD-236B Oral Tablet
Locations (1)
H+ Yangji Hospital, Seoul,
Seoul, South Korea